Torrent Pharmaceuticals Ltd. Conference Calls and Earnings Call Transcripts

Torrent Pharmaceuticals Ltd. Conference Calls and Earnings Call Transcripts: Get insights into company performance, financials, capex plans, and more.

announcement
Conference/Earnings Calls Alerts
3606.70
0.66%
TORRENT PHARMACEUTICALS LTD. - 500420 - Audio Recording Of Conference Call With Analysts / Investors On …
BSE India
In continuation of our letter dated 12-Jan-23 and pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the audio recording of Conference call with Analysts / Investors on Financial Results of the Company for the quarter and nine months ended 31st December, 2022, has been placed on the Company's website at https://www.torrentpharma.com/pdf/investors/Audio_Recording31122022.mp3
3606.70
0.66%
Conference Call with Torrent Pharmaceuticals Management and Analysts on Q3FY23 Performance and Outlook. Listen to the full earnings transcript.
3606.70
0.66%
3606.70
0.66%
TORRENT PHARMACEUTICALS LTD. - 500420 - Audio Recording Of Conference Call With Analysts / Investors On …
BSE India
In continuation of our letter dated 14-Oct-22 and pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the audio recording of Conference call with Analysts / Investors on Financial Results of the Company for the quarter and half year ended 30th September, 2022, has been placed on the Company's website at https://www.torrentpharma.com/pdf/investors/Audio_Recording30092022.mp3
3606.70
0.66%

Conference Call with Torrent Pharmaceuticals Management and Analysts on its acquisition of Curatio Healthcare. Listen to the full transcript.

3606.70
0.66%
3606.70
0.66%
Conference Call with Torrent Pharmaceuticals Management and Analysts on Q1FY23 Performance and Outlook. Listen to the full earnings transcript.
3606.70
0.66%
TORRENT PHARMACEUTICALS LTD. - 500420 - Audio Recording Of Conference Call With Analysts / Investors On …
BSE India
In continuation of our letter dated 21-Jul-22 and pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the audio recording of Conference call with Analysts / Investors on Financial Results of the Company for the quarter ended 30th June, 2022, has been placed on the Company's website at https://www.torrentpharma.com/pdf/investors/Audio_Recording30062022.mp3
3606.70
0.66%
3606.70
0.66%
Conference Call with Torrent Pharmaceuticals Management and Analysts on Q4FY22 Performance and Outlook. Listen to the full earnings transcript.

Earnings Calls Podcast on